Literature DB >> 25135871

Evaluation of neutrophil gelatinase-associated lipocalin, interleukin-18, and cystatin C as molecular markers before and after unilateral shock wave lithotripsy.

Ioannis S Kardakos1, Demetrios I Volanis1, Aggeliki Kalikaki1, Vasilleios P Tzortzis2, Efraim N Serafetinides3, Michael D Melekos2, Demetrios S Delakas2.   

Abstract

OBJECTIVE: To investigate the impact of shock wave lithotripsy (SWL) on renal tissues using neutrophil gelatinase-associated lipocalin (NGAL), cystatin C, and interleukin 18 (IL-18) levels in serum and urine and to examine the relationship of these biomarkers with patient and calculus characteristics as well as SWL treatment parameters.
MATERIALS AND METHODS: Thirty-seven patients with renal calculi were included in this study. Blood and urine samples were attained from each patient at 4 time points; immediately before SWL, 6 hours after, 3 days after, and 10 days after the SWL. A new generation lithotripter was used for all cases. Serum and urine NGAL concentrations were measured using commercially available enzyme-linked immunosorbent assay kits according to manufacture's protocol. The concentration of cystatin C was measured in serum, whereas IL-18 concentration was assessed in urine.
RESULTS: There were no statistically significantly differences in the levels of NGAL in serum and urine before and after SWL. The mean levels of cystatin C in serum appeared significantly higher 3 and 10 days after SWL. No statistically significant differences were identified between levels of IL-18 before and after SWL. Patients with diabetes mellitus demonstrated significantly higher baseline cystatin C levels. There was no correlation between calculus characteristics or treatment parameters and the levels of all 3 biomarkers after SWL.
CONCLUSION: The results of this study indicate that SWL is associated with minimal acute injury to renal tissues. Our findings support the safety profile of new generation lithotripters, provided orthodox indications and treatment principles are followed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25135871     DOI: 10.1016/j.urology.2014.05.034

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Urinary extracellular vesicle-associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls.

Authors:  Robin S Chirackal; Muthuvel Jayachandran; Xiangling Wang; Samuel Edeh; Zejfa Haskic; Majuran Perinpam; Timothy M Halling; Ramila Mehta; Marcelino E Rivera; John C Lieske
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

2.  Development of a novel magnetic resonance imaging acquisition and analysis workflow for the quantification of shock wave lithotripsy-induced renal hemorrhagic injury.

Authors:  Rajash K Handa; Paul R Territo; Philip M Blomgren; Scott A Persohn; Chen Lin; Cynthia D Johnson; Lei Jiang; Bret A Connors; Gary D Hutchins
Journal:  Urolithiasis       Date:  2017-01-10       Impact factor: 3.436

3.  Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis.

Authors:  Mehmet Taşdemir; Dilara Fuçucuoğlu; Suat Hayri Küçük; Meltem Erol; Özgül Yiğit; Ilmay Bilge
Journal:  Clin Exp Nephrol       Date:  2017-06-26       Impact factor: 2.801

4.  Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy.

Authors:  Matteo Vittori; Silvia Baroni; Pietro Manuel Ferraro; Giovanni Gambaro; Renato Morelli; PierFrancesco Bassi; Alessandro D'Addessi
Journal:  Urolithiasis       Date:  2016-10-27       Impact factor: 3.436

5.  Urinary neutrophil gelatinase-associated lipocalin level as a biomarker of acute kidney injury following extracorporeal shock wave lithotripsy.

Authors:  Emir Milišić; Jasmin Alić; Zlatan Zvizdić; Orhan Lepara; Asmir Jonuzi; Lejla Milišić; Almir Fajkić
Journal:  Cent European J Urol       Date:  2021-11-02

6.  Shock wave lithotripsy, for the treatment of kidney stones, results in changes to routine blood tests and novel biomarkers: a prospective clinical pilot-study.

Authors:  Stephen F Hughes; Nathan Jones; Samantha J Thomas-Wright; Joseph Banwell; Alyson J Moyes; Iqbal Shergill
Journal:  Eur J Med Res       Date:  2020-06-01       Impact factor: 2.175

7.  A Network Pharmacology Study on the Mechanisms of the Herbal Extract, Christina Loosestrife, for the Treatment of Nephrolithiasis.

Authors:  Kun Yu; Ping Zhang; Zhen-Guo Xie
Journal:  Med Sci Monit       Date:  2020-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.